T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy

S.J.A.M. Santegoets, A.J.M. van den Eertwegh, A.G.M. Stam, R.J. Scheper, S.M. Lougheed, P.E. Scholten, B.M.E. von Blomberg, H. Gall, K. Jooss, N. Sacks, T. Harding, K. Hege, I. Lowy, W.R. Gerritsen, T.D. de Gruijl

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)918-919
JournalJournal of Immunotherapy
Volume33
Issue number8
Publication statusPublished - 2010

Cite this

@article{7999669c1d1b450eb1abfbee8e296ffa,
title = "T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy",
author = "S.J.A.M. Santegoets and {van den Eertwegh}, A.J.M. and A.G.M. Stam and R.J. Scheper and S.M. Lougheed and P.E. Scholten and {von Blomberg}, B.M.E. and H. Gall and K. Jooss and N. Sacks and T. Harding and K. Hege and I. Lowy and W.R. Gerritsen and {de Gruijl}, T.D.",
year = "2010",
language = "Undefined/Unknown",
volume = "33",
pages = "918--919",
journal = "Journal of Immunotherapy",
issn = "1524-9557",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy. / Santegoets, S.J.A.M.; van den Eertwegh, A.J.M.; Stam, A.G.M.; Scheper, R.J.; Lougheed, S.M.; Scholten, P.E.; von Blomberg, B.M.E.; Gall, H.; Jooss, K.; Sacks, N.; Harding, T.; Hege, K.; Lowy, I.; Gerritsen, W.R.; de Gruijl, T.D.

In: Journal of Immunotherapy, Vol. 33, No. 8, 2010, p. 918-919.

Research output: Contribution to journalMeeting AbstractOther research output

TY - JOUR

T1 - T Cell Activation, PSMA Seroconversion and Increased Th17 Rates are Associated with Favorable Clinical Outcome in Prostate Cancer Patients Treated with Prostate GVAX and Anti-CTLA4 Immunotherapy

AU - Santegoets, S.J.A.M.

AU - van den Eertwegh, A.J.M.

AU - Stam, A.G.M.

AU - Scheper, R.J.

AU - Lougheed, S.M.

AU - Scholten, P.E.

AU - von Blomberg, B.M.E.

AU - Gall, H.

AU - Jooss, K.

AU - Sacks, N.

AU - Harding, T.

AU - Hege, K.

AU - Lowy, I.

AU - Gerritsen, W.R.

AU - de Gruijl, T.D.

PY - 2010

Y1 - 2010

M3 - Meeting Abstract

VL - 33

SP - 918

EP - 919

JO - Journal of Immunotherapy

JF - Journal of Immunotherapy

SN - 1524-9557

IS - 8

ER -